Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
ConciergeMD uses a medical evaluation to determine whether or not the peptide therapy is appropriate
GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023. These medications alter glucose metabolism, gastric motility, and sympathetic tone, which may lead to unique uptake patterns on PET-CT
If hot flashes and vasomotor symptoms are primary, we consider transdermal estrogen patches
Factors that influence this include: Baseline B12 levels Symptoms and severity Absorption issues or medical conditions Diet and lifestyle factors Some people maintain healthy levels with occasional injections, while others require more consistent support
